Cases 1 - 10 of 81
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. CIPLA USA, INC. et al
as 2:2024cv00909
Plaintiff:
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and NORTON (WATERFORD) LTD.
Defendant:
CIPLA USA, INC. and CIPLA LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2024cv00150
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (f/k/a GW RESEARCH LIMITED) v. APOTEX INC. et al
as 2:2023cv23141
Plaintiff:
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (f/k/a GW RESEARCH LIMITED)
Defendant:
APOTEX INC., INVAGEN PHARMACEUTICALS, INC., CIPLA LTD. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Cipla Ltd. et al
as 1:2023cv01196
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Cipla Ltd., Cipla USA Inc. and Invagen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hikma Pharmaceuticals USA Inc. v. Cipla USA, Inc. et al
as 1:2023cv01157
Plaintiff:
Hikma Pharmaceuticals USA Inc.
Defendant:
Cipla USA, Inc. and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv03914
Plaintiff:
GW RESEARCH LIMITED
Defendant:
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mitsubishi Tanabe Pharma Corporation v. Cipla USA, Inc. et al
as 1:2023cv00759
Plaintiff:
Mitsubishi Tanabe Pharma Corporation
Defendant:
Cipla USA, Inc. and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Cipla Limited et al
as 1:2023cv00389
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2023cv00287
Plaintiff:
Exelixis, Inc.
Defendant:
Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
